| Application no. and date | 14751254.5 (espacenet) (Federated) (European Patent Register), 20140214 | | Patent/reg. no. and date | DK/EP 2956477, 20201118 | | Publication date | 20151223 | | Priority no. and date | US 201361765626 P, 20130215 | | EP pub. no. and date |
EP 2956477 20151223 | | Effective date | | | Applicant/owner | Bioverativ Therapeutics Inc., 225 Second Avenue
Waltham, MA 02451, US | | Applicant ref. no. | 1699438 | | Inventor | TAN, Siyuan, 53 Buckman Drive
Lexington, Massachusetts 02421, US,
PETERS, Robert, T., 53 Parkinson Street
Needham, Massachusetts 02492, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07K 14/755 (2006.01) | | Title | OPTIMERET FAKTOR VIII-GEN | | Int. application no. | US2014016441 | | Int. publication no. | WO2014127215 | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
